AU2018213977B2 - Method for detecting basophil activation - Google Patents

Method for detecting basophil activation Download PDF

Info

Publication number
AU2018213977B2
AU2018213977B2 AU2018213977A AU2018213977A AU2018213977B2 AU 2018213977 B2 AU2018213977 B2 AU 2018213977B2 AU 2018213977 A AU2018213977 A AU 2018213977A AU 2018213977 A AU2018213977 A AU 2018213977A AU 2018213977 B2 AU2018213977 B2 AU 2018213977B2
Authority
AU
Australia
Prior art keywords
basophils
chemiluminescence
ligand
allergen
cell surface
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
AU2018213977A
Other languages
English (en)
Other versions
AU2018213977A1 (en
Inventor
Julia GRUHNE
Henning Seismann
Alf WEIMANN
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Euroimmun Medizinische Labordiagnostika AG
Original Assignee
Euroimmun Medizinische Labordiagnostika AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP17001352.8A external-priority patent/EP3441763A1/de
Application filed by Euroimmun Medizinische Labordiagnostika AG filed Critical Euroimmun Medizinische Labordiagnostika AG
Publication of AU2018213977A1 publication Critical patent/AU2018213977A1/en
Application granted granted Critical
Publication of AU2018213977B2 publication Critical patent/AU2018213977B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
    • G01N33/6869—Interleukin
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/566—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/41—Detecting, measuring or recording for evaluating the immune or lymphatic systems
    • A61B5/411—Detecting or monitoring allergy or intolerance reactions to an allergenic agent or substance
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/75—Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated
    • G01N21/76—Chemiluminescence; Bioluminescence
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5047—Cells of the immune system
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5091—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5094—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for blood cell populations
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • G01N33/56972—White blood cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/577—Immunoassay; Biospecific binding assay; Materials therefor involving monoclonal antibodies binding reaction mechanisms characterised by the use of monoclonal antibodies; monoclonal antibodies per se are classified with their corresponding antigens
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/24—Immunology or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Plasma & Fusion (AREA)
  • Ecology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physiology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Medical Informatics (AREA)
  • Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Virology (AREA)
  • Rehabilitation Therapy (AREA)
  • Rheumatology (AREA)
AU2018213977A 2017-08-08 2018-08-06 Method for detecting basophil activation Active AU2018213977B2 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP17001352.8A EP3441763A1 (de) 2017-08-08 2017-08-08 Verfahren zum nachweis einer basophilenaktivierung
EP17001352.8 2017-08-08
EP17001979.8 2017-12-05
EP17001979 2017-12-05

Publications (2)

Publication Number Publication Date
AU2018213977A1 AU2018213977A1 (en) 2019-02-28
AU2018213977B2 true AU2018213977B2 (en) 2025-02-20

Family

ID=63041937

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2018213977A Active AU2018213977B2 (en) 2017-08-08 2018-08-06 Method for detecting basophil activation

Country Status (13)

Country Link
US (1) US11119109B2 (enExample)
EP (1) EP3441765B1 (enExample)
JP (1) JP7265325B2 (enExample)
KR (1) KR102547565B1 (enExample)
CN (1) CN109387636B (enExample)
AU (1) AU2018213977B2 (enExample)
BR (1) BR102018015288A2 (enExample)
CA (1) CA3012989A1 (enExample)
DE (1) DE102018006212A1 (enExample)
ES (1) ES2904354T3 (enExample)
LT (1) LT3441765T (enExample)
PL (1) PL3441765T3 (enExample)
SG (1) SG10201806697RA (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20210382070A1 (en) * 2020-06-04 2021-12-09 The Chinese University Of Hong Kong Diagnostic biomarkers for shrimp allergy
CN112630423A (zh) * 2020-12-31 2021-04-09 杭州福德敏生物技术有限公司 一种小麦免疫荧光检测试纸条及应用
KR102497904B1 (ko) * 2021-02-10 2023-02-10 재단법인 아산사회복지재단 세포 원심분리 및 농축을 이용한 면역세포 검출 방법 및 면역세포 검출용 칩

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2037269A1 (en) * 2007-09-11 2009-03-18 Bühlmann Laboratories AG Allergy test based on flow cytometric analysis
WO2012044756A2 (en) * 2010-10-01 2012-04-05 The Board Of Trustees Of The Leland Stanford Junior University Basophil activation based allergy diagnostic test

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3169833D1 (en) 1980-08-22 1985-05-15 Berthold Lab Prof R Process for performing analytical determinations by means of the chemiluminescent method, and application of this process to immuno assays
US4902613A (en) 1984-05-14 1990-02-20 Becton, Dickinson And Company Lysing agent for analysis of peripheral blood cells
EP0182874B1 (en) 1984-05-31 1993-10-20 Coulter Corporation A reagent system and method for identification, enumeration and examination of classes and subclasses of blood leukocytes
WO1998032014A1 (de) 1997-01-20 1998-07-23 Orpegen Pharma Gmbh Basophilen-degranulationstest
FR2778413B1 (fr) 1998-05-07 2000-08-04 Immunotech Sa Nouveaux reactifs et methode de lyse des erythrocytes
CZ292686B6 (cs) * 2001-09-17 2003-11-12 Imumed S. R. O. Způsob měření aktivace basofilů po stimulaci alergenem pro stanovení přecitlivělosti na tento alergen a příslušný kit
DE10235310B4 (de) 2002-08-01 2012-05-16 Molecular And Clinical Drug Research Verfahren zur Bestimmung allergener Potenz von Produkten
RU2289138C2 (ru) * 2004-12-14 2006-12-10 Научно-исследовательский институт микробиологии Министерства обороны Российской Федерации Способ аллергодиагностики по показателям хемилюминесцентного свечения нейтрофилов
JP2009236798A (ja) 2008-03-28 2009-10-15 Sysmex Corp 好塩基球の分類計数方法
US20100167317A1 (en) * 2008-08-05 2010-07-01 Institut Pasteur Process for enriching basophils in a blood sample
WO2012028167A2 (en) 2010-05-20 2012-03-08 Innohyphen Bv Acridinium ester chemiluminescence upon reductive triggering
WO2012105541A1 (ja) 2011-01-31 2012-08-09 大鵬薬品工業株式会社 新規ヒノキ花粉アレルゲン
US20150299315A1 (en) * 2012-10-22 2015-10-22 Becton, Dickinson And Company Non-b-lineage cells capable of producing antibody
EP3051928B1 (de) 2015-01-29 2019-01-16 Kjellberg-Stiftung Plasmabrenner
CN104677810B (zh) * 2015-01-30 2017-08-22 广东医学院附属医院 嗜碱性粒细胞活化的检测试剂盒及其使用方法
CN104777303B (zh) * 2015-04-29 2017-02-01 何韶衡 一种嗜碱性粒细胞激活、脱颗粒的鉴定方法
HUE047265T2 (hu) 2016-01-25 2020-04-28 Euroimmun Medizinische Labordiagnostika Ag Makadámia allergén
EP3244212A1 (en) 2017-02-15 2017-11-15 Euroimmun Medizinische Labordiagnostika AG An improved assay for the diagnosis of peanut allergy

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2037269A1 (en) * 2007-09-11 2009-03-18 Bühlmann Laboratories AG Allergy test based on flow cytometric analysis
WO2012044756A2 (en) * 2010-10-01 2012-04-05 The Board Of Trustees Of The Leland Stanford Junior University Basophil activation based allergy diagnostic test

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
"Basotest Reagent kit for the quantitative determination of the degranulation of basophilic granulocytes in heparinized human whole blood", 4 August 2016, Retrieved from the Internet *
Saarne, T. et al. "Rational design of hypoallergens applied to the major cat allergen Fel d 1". Clin Exp Allergy. 2005 May;35(5):657-63. doi: 10.1111/j.1365-2222.2005.02234.x. PMID: 15898990. *

Also Published As

Publication number Publication date
JP2019032317A (ja) 2019-02-28
ES2904354T3 (es) 2022-04-04
US20190049461A1 (en) 2019-02-14
KR20190016446A (ko) 2019-02-18
KR102547565B1 (ko) 2023-06-26
SG10201806697RA (en) 2019-03-28
JP7265325B2 (ja) 2023-04-26
LT3441765T (lt) 2022-01-10
AU2018213977A1 (en) 2019-02-28
US11119109B2 (en) 2021-09-14
DE102018006212A1 (de) 2019-02-14
CN109387636B (zh) 2023-07-04
CA3012989A1 (en) 2019-02-08
PL3441765T3 (pl) 2022-02-14
EP3441765A1 (de) 2019-02-13
EP3441765B1 (de) 2021-10-20
BR102018015288A2 (pt) 2021-11-09
CN109387636A (zh) 2019-02-26

Similar Documents

Publication Publication Date Title
CN102144161B (zh) 泛激酶活化与信号通路的评估
EP2037269B1 (en) Allergy test based on flow cytometric analysis
EP2972348B1 (en) Methods of detecting donor-specific antibodies
Morais et al. Biosensors for food allergy detection according to specific IgE levels in serum
WO2003081240A1 (fr) Procede de recherche d'infection virale
AU2018213977B2 (en) Method for detecting basophil activation
US20150010903A1 (en) Real Time Diagnostic Assays Using an Evanescence Biosensor
US11513119B2 (en) Flow cytometry system and methods for the diagnosis of infectious disease
JP4272431B2 (ja) 診断試験法
US20160041185A1 (en) Methods of Detecting Complement Fixing and Non-Complement Fixing Antibodies and Systems for Practicing the Same
RU2289138C2 (ru) Способ аллергодиагностики по показателям хемилюминесцентного свечения нейтрофилов
JPWO2004048975A1 (ja) 黄色ブドウ球菌の検査方法
Kaur et al. Pull Down Assay-Based Protein Analysis
EP3441763A1 (de) Verfahren zum nachweis einer basophilenaktivierung
AU2013366066A1 (en) Immunoassay
JPWO2004061452A1 (ja) 抗体の測定方法
US20030022250A1 (en) Functional IgE test methods and compositions
Lin et al. Luciferase Immunoprecipitation Systems immunoassay is a sensitive, rapid method to detect allergen component-specific IgE
Alvesa et al. Application of the chemiluminescence systems to evaluate the role of Fcg and complement receptors in stimulating the oxidative burst in neutrophils
JPH11211726A (ja) 脱髄疾患の検出方法
UA63744A (en) Method for assessing degree of myocardial hypertrophy in patients with hypertension, grade 2
UA63745A (en) Method for detecting hypertrophic or destructive processes in patients with cardiovascular diseases

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)